annual cash & cash equivalents:
$150.00M+$23.00M(+18.11%)Summary
- As of today (September 16, 2025), RCUS annual cash & cash equivalents is $150.00 million, with the most recent change of +$23.00 million (+18.11%) on December 31, 2024.
- During the last 3 years, RCUS annual cash & cash equivalents has risen by +$2.00 million (+1.35%).
- RCUS annual cash & cash equivalents is now -27.18% below its all-time high of $206.00 million, reached on December 31, 2022.
Performance
RCUS Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$911.00M-$86.00M(-8.63%)Summary
- As of today (September 16, 2025), RCUS quarterly cash & cash equivalents is $911.00 million, with the most recent change of -$86.00 million (-8.63%) on June 30, 2025.
- Over the past year, RCUS quarterly cash & cash equivalents has dropped by -$58.00 million (-5.99%).
- RCUS quarterly cash & cash equivalents is now -24.93% below its all-time high of $1.21 billion, reached on March 31, 2022.
Performance
RCUS quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RCUS Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.1% | -6.0% |
| 3 y3 years | +1.4% | -22.3% |
| 5 y5 years | +158.9% | +97.0% |
RCUS Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.2% | +18.1% | -22.3% | +20.0% |
| 5 y | 5-year | -27.2% | +158.9% | -24.9% | +97.0% |
| alltime | all time | -27.2% | +158.9% | -24.9% | +477.1% |
RCUS Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $911.00M(-8.6%) |
| Mar 2025 | - | $997.00M(+1.9%) |
| Dec 2024 | $150.00M(+18.1%) | $978.00M(-10.2%) |
| Sep 2024 | - | $1.09B(+12.4%) |
| Jun 2024 | - | $969.00M(-2.6%) |
| Mar 2024 | - | $995.00M(+31.1%) |
| Dec 2023 | $127.00M(-38.3%) | $759.00M(-5.0%) |
| Sep 2023 | - | $799.00M(-14.1%) |
| Jun 2023 | - | $930.00M(-2.5%) |
| Mar 2023 | - | $954.00M(-5.5%) |
| Dec 2022 | $206.00M(+39.2%) | $1.01B(-3.8%) |
| Sep 2022 | - | $1.05B(-10.6%) |
| Jun 2022 | - | $1.17B(-3.4%) |
| Mar 2022 | - | $1.21B(+143.0%) |
| Dec 2021 | $148.00M | $499.31M(-4.8%) |
| Sep 2021 | - | $524.64M(-27.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $721.01M(-12.8%) |
| Mar 2021 | - | $826.93M(+13.5%) |
| Dec 2020 | $173.41M(+199.3%) | $728.65M(-6.9%) |
| Sep 2020 | - | $782.43M(+69.2%) |
| Jun 2020 | - | $462.47M(+193.0%) |
| Mar 2020 | - | $157.87M(-16.1%) |
| Dec 2019 | $57.94M(-18.5%) | $188.27M(-1.4%) |
| Sep 2019 | - | $190.99M(-14.9%) |
| Jun 2019 | - | $224.40M(-7.2%) |
| Mar 2019 | - | $241.94M(-5.7%) |
| Dec 2018 | $71.06M(-27.8%) | $256.54M(-0.5%) |
| Sep 2018 | - | $257.84M(-3.0%) |
| Jun 2018 | - | $265.70M(-5.2%) |
| Mar 2018 | - | $280.18M(+59.5%) |
| Dec 2017 | $98.43M(+51.1%) | $175.70M |
| Dec 2016 | $65.16M | - |
FAQ
- What is Arcus Biosciences, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. annual cash & cash equivalents year-on-year change?
- What is Arcus Biosciences, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
What is Arcus Biosciences, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of RCUS is $150.00M
What is the all time high annual cash & cash equivalents for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high annual cash & cash equivalents is $206.00M
What is Arcus Biosciences, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, RCUS annual cash & cash equivalents has changed by +$23.00M (+18.11%)
What is Arcus Biosciences, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of RCUS is $911.00M
What is the all time high quarterly cash & cash equivalents for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high quarterly cash & cash equivalents is $1.21B
What is Arcus Biosciences, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, RCUS quarterly cash & cash equivalents has changed by -$58.00M (-5.99%)